Lead Generation - EME Access Message | Access control messages | Drug Target Review

Skip to main content
Skip to navigation

Topics

Neurological disorders

Related articles

Article
Turning CRISPR hits into confident drug discovery decisions

2026-05-07T12:30:00Z

By Dr Salman Tamaddon-Jahromi
News
Machine learning identifies five distinct Parkinson’s disease subtypes

2026-05-05T09:00:00Z

By Drug Target Review
Article
Why lower organisms matter for neurodegeneration drug discovery

2026-04-27T07:00:00Z

By Dr Christopher Saunter
News
Nasal spray reverses age-related brain inflammation in preclinical study

2026-04-16T12:00:00Z

By Drug Target Review
Article
Beyond serendipity: rational design and AI’s expansion of the undruggable target landscape

2026-04-15T13:14:00Z

By Vincenzo Gioia, Paolo D’Ambrosio and Dr Remco Jan Geukes Foppen
News
Combining antibodies with natural compounds may improve Alzheimer’s treatment

2026-04-13T10:14:00Z

By Drug Target Review

Partner content

Webinar
What it takes to automate high-content imaging at scale

2026-03-25T15:00:00 2026-03-25T16:00:00

Sponsored by Yokogawa
Webinar
The truth about AI in drug discovery: what the experts really think

2026-03-11T14:00:00

Sponsored by Merck
Article
CRISPR/Cas: exploring its impact on gene editing

2024-03-08T10:00:25

Sponsored by Molecular Devices
Whitepaper
Infographic: Targeted protein degradation

2023-05-23T11:10:47

Sponsored by NanoTemper Technologies
Whitepaper
eBook: Modern Microscopy in Cancer Research

2024-01-10T08:56:17

Sponsored by Leica Microsystems
Webinar
Where NAMs stand in early drug discovery: an expert discussion

2026-06-24T13:00:00 2026-06-24T14:00:00

Sponsored by HUB Organoids